Pharma giant AstraZeneca (AZN) is transitioning its U.S. listing by delisting American Depositary Shares (ADS) from Nasdaq and directly listing its ordinary shares on the New York Stock Exchange (NYSE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results